Printer Friendly

INAMED CORP. REPORTS RESULTS

 INAMED CORP. REPORTS RESULTS
 SANTA BARBARA, Calif., May 18 /PRNewswire/ -- INAMED Corp.


(NASDAQ: IMDC), a medical and surgical device company that develops and markets products to specialty medical markets, headquartered here, today reported record sales of $16,731,906 for the first quarter ended March 31, 1992. This represents a 73 percent increase over sales of $9,650,500 reported for the first quarter of 1991.
 First quarter net income of $1,007,374, or $.12 per share, represents a 653 percent increase over net income of $133,698, or $.02 per share, in the same quarter of 1991. Pre-tax operating income rose 432 percent to $2,777,835 from $575,358.
 "Despite the very severe setbacks which the entire industry faced in January 1992 when Dr. Kessler of the U.S. Food and Drug Administration (FDA) called for a voluntary moratorium on silicone gel-filled breast implants, the company's first quarter results indicate that the majority of physicians who perform breast implant surgery, as well as the majority of women who seek that surgery for cosmetic or reconstructive reasons, still have confidence that the industry manufactures safe and effective products," said INAMED Chairman of the Board Donald K. McGhan. "Although the company is still unable to manufacture or ship gel-filled implants, our customers are accepting the company's saline-filled implants for most applications. The company does expect to renew manufacturing and shipping of gel-filled implants as soon as the FDA allows."
 INAMED Corp.
 Earnings Recap
 Quarter Ended Quarter Ended
 March 31, 1992 March 31, 1991
 Net sales $16,731,906 $9,650,500
 Operating income 2,777,835 575,358
 Income before income taxes 2,173,433 408,698
 Net income 1,007,374 133,698
 Profit per share $.12 $.02
 Weighted average number of
 shares outstanding 8,206,310 7,995,104
 -0- 5/18/92
 /CONTACT: Donald K. McGhan, chairman of INAMED, 805-684-6277; or Jimmy Caplan of Market Makers, 805-569-6919, for INAMED/
 (IMDC) CO: INAMED Corp. ST: California IN: MTC SU: ERN


DM-JL -- LA016 -- 1144 05/18/92 09:02 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 18, 1992
Words:342
Previous Article:INTERTEL COMMUNICATIONS ANNOUNCES RECORD SECOND QUARTER REVENUES, TOP MANAGEMENT CHANGES
Next Article:REHAB HOSPITALS DIVISION (NME) PURCHASES SECOND ERGOS(TM) FOR ITS NATIONAL NETWORK
Topics:


Related Articles
INAMED BRINGS PATENT INFRINGEMENT SUIT AGAINST BIOPLASTY
INAMED CORP. VOLUNTARILY SUSPENDS SHIPMENTS OF GEL-FILLED BREAST IMPLANTS
INAMED CORP. VOLUNTARILY SUSPENDS SHIPMENTS OF GEL-FILLED BREAST IMPLANTS
INAMED SUBSIDIARY HALTS SUIT FILED AGAINST FDA AND COMMISSIONER KESSLER
INAMED REPORTS RECORD SECOND QUARTER AND SIX-MONTH SALES AND PROFITS
INAMED REPORTS RECORD SALES FOR 1992
INAMED SCHEDULES ADJOURNED ANNUAL MEETING
TWO INAMED OFFICERS PURCHASE 400,000 SHARES OF COMPANY STOCK
INAMED CORP. REPORTS RECORD SALES FOR 1993; COMPANY TO TAKE LITIGATION SETTLEMENT ADJUSTMENT OF $9.15 MILLION
INAMED CORP. REPORTS SECOND QUARTER AND SIX MONTHS RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters